Evidence map›Paper›PMID 32279223›Full record

Trial reportJournal of autism and developmental disorders2020

Exploring Social Biomarkers in High-Functioning Adults with Autism and Asperger's Versus Healthy Controls: A Cross-Sectional Analysis.

Marta Del Valle Rubido, Eric Hollander, James T McCracken, Frederick Shic, Jana Noeldeke, Lauren Boak, Omar Khwaja, Shamil Sadikhov, Paulo Fontoura, Daniel Umbricht

Erratum issuedAbstract readClinical TrialMulticenter StudyObservational Study
In one paragraph

Trial report in Journal of autism and developmental disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trends Over Time in the Prevalence of Autism by Adaptive and Intellectual Functioning Levels.Autism research : official journal of the International Society for Autism Research · 2026
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Marta Del Valle RubidoRoche Innovation Center Basel, Roche Pharmaceutical Research and Early Development, NRD, Basel, Switzerland. marta.del_valle_rubido@roche.com.
Eric HollanderPsychiatry and Behavioral Sciences, Albert Einstein College of Medicine and Montefiore Medicine, Bronx, NY, USA.
James T McCrackenPsychiatry and Behavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Frederick ShicCenter for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, WA, USA.
Jana NoeldekeRoche Innovation Center Basel, Roche Pharmaceutical Research and Early Development, NRD, Basel, Switzerland.
Lauren BoakRoche Product Development Neuroscience, Basel, Switzerland.
Omar KhwajaRoche Innovation Center Basel, Roche Pharmaceutical Research and Early Development, NRD, Basel, Switzerland.
Shamil SadikhovRoche Product Development Neuroscience, Basel, Switzerland.
Paulo FontouraRoche Product Development Neuroscience, Basel, Switzerland.
Daniel UmbrichtRoche Innovation Center Basel, Roche Pharmaceutical Research and Early Development, NRD, Basel, Switzerland.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Biomarkers for autism spectrum disorder (ASD) are lacking but would facilitate drug development for the core deficits of the disorder. We evaluated markers proposed for characterization of differences in social communication and interaction in adults with ASD versus healthy controls (HC) for utility as biomarkers. Data pooled from an observational study and baseline data from a placebo-controlled study were analyzed. Between-group differences were observed in eye-tracking tasks for activity monitoring, biomotion, human activity preference, composite score (p = 0.0001-0.037) and pupillometry (various tasks, p = 0.017-0.05). Impaired olfaction was more common in the ASD sample versus HC (p = 0.018). Our preliminary results suggest the potential use for stratification and response sub-analyses outcome-prediction of specific eye-tracking tasks, pupillometry and olfaction tests in ASD trials.

Indexed as

Social BehaviorAdolescentAdultAsperger SyndromeAutistic DisorderCross-Sectional StudiesDouble-Blind MethodEye-Tracking TechnologyHumansMaleSmellYoung AdultBiomarkerEye movementOlfactorySocial cognition

Identifiers

PMID32279223
PMCPMC7677266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.